Abnormal neurological signs, visual contrast sensitivity, and the deficit syndrome of schizophrenia

Progress in Neuro-psychopharmacology & Biological Psychiatry
Csongor CimmerSzabolcs Kéri

Abstract

This study was designed to investigate the relationship between abnormal neurological signs, visual contrast sensitivity, and the deficit syndrome of schizophrenia. Visual contrast sensitivity for counterphase-modulated low spatial frequency gratings was measured in 32 non-deficit and 12 deficit schizophrenia patients and 20 healthy controls subjects. Abnormal neurological signs were evaluated with the Neurological Evaluation Scale (NES). Compared with the controls, patients with schizophrenia displayed impaired visual contrast sensitivity, which was associated with sensory integration deficits, as measured with the NES. The deficit syndrome was predicted by negative symptoms and sensory integration deficits. These results suggest that early-stage perceptual dysfunctions, which may reflect the abnormality of precortical magnocellular visual pathways, are related to a specific group of abnormal neurological signs.

References

May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T R Barnes
Nov 1, 1989·Psychiatry Research·B KirkpatrickW T Carpenter
Jan 1, 1988·Schizophrenia Bulletin·W T Carpenter, B Kirkpatrick
Jan 1, 1988·The American Journal of Psychiatry·D W Heinrichs, R W Buchanan
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Mar 1, 1997·The American Journal of Psychiatry·R W BuchananW T Carpenter
May 1, 1997·The American Journal of Psychiatry·J R BustilloW T Carpenter
Mar 30, 2000·The American Journal of Psychiatry·C ArangoR W Buchanan
Feb 15, 2001·Frontiers in Bioscience : a Journal and Virtual Library·B D SchwartzK V Ross
Feb 15, 2001·Archives of General Psychiatry·B KirkpatrickW T Carpenter
Jun 30, 2001·The American Journal of Psychiatry·P D ButlerD C Javitt
May 2, 2002·The Journal of Neuropsychiatry and Clinical Neurosciences·Szabolcs KériZoltán Janka
Jul 2, 2003·The American Journal of Psychiatry·Matcheri S KeshavanNina R Schooler
Aug 2, 2003·Schizophrenia Research·L Elliot HongGunvant K Thaker
Sep 25, 2003·European Archives of Psychiatry and Clinical Neuroscience·Ahmet TiryakiAhmet Göğüş
Sep 30, 2003·The American Journal of Psychiatry·Yue ChenPhilip S Holzman
Oct 23, 2003·Brain : a Journal of Neurology·Paola DazzanRobin M Murray
Aug 5, 2004·Neuropsychology·Szabolcs KériZoltán Janka
May 4, 2005·Archives of General Psychiatry·Pamela D ButlerDaniel C Javitt
Aug 2, 2005·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Isaac SchechterDaniel C Javitt

❮ Previous
Next ❯

Citations

Sep 18, 2007·Psychopharmacology·Olivia L CarterFranz X Vollenweider
Oct 18, 2011·Expert Opinion on Medical Diagnostics·Ivan KoychevJohn Francis William Deakin
Nov 6, 2009·Schizophrenia Research·Alex S CohenKyle S Minor
Sep 2, 2008·Physiology & Behavior·Gabor TubolyGyöngyi Horvath
Oct 7, 2008·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Brian Kirkpatrick, Silvana Galderisi
Oct 22, 2013·Vision Research·Neda Khosravani, Mohammad Ali Goodarzi
May 7, 2013·Vision Research·Denis G Pelli, Peter Bex
Sep 11, 2007·Vision Research·Bernt C Skottun, John R Skoyles
Jun 1, 2016·Schizophrenia Research·Armida MucciSilvana Galderisi
Nov 4, 2016·Scandinavian Journal of Psychology·Zohreh Ansari, Javad Salehi Fadardi
Nov 30, 2019·Experimental Brain Research·Lauren HarperClaire V Hutchinson
Nov 20, 2018·Journal of Vision·Scott W J MooneyGlen T Prusky
Oct 30, 2020·The European Journal of Neuroscience·Vance ZemonPamela D Butler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here